Spero Therapeutics, Inc.SPRONASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank44
3Y CAGR-22.3%
5Y CAGR+12.2%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-22.3%/yr
vs +6.6%/yr prior
5Y CAGR
+12.2%/yr
Recent deceleration
Acceleration
-28.8pp
Decelerating
Percentile
P44
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $52.89M | -30.7% |
| 2023 | $76.33M | -30.0% |
| 2022 | $109.11M | -3.1% |
| 2021 | $112.58M | +32.1% |
| 2020 | $85.21M | +186.6% |
| 2019 | $29.73M | -12.8% |
| 2018 | $34.08M | -61.0% |
| 2017 | $87.29M | +746.2% |
| 2016 | $10.31M | +81.3% |
| 2015 | $5.69M | - |